Former U.S. President Bill Clinton and drugmakers Pfizer and Matrix Laboratories Ltd announced a deal on Thursday to lower the cost of treatments for patients with drug-resistant forms of HIV/AIDS.
Second-line antiretroviral therapies and a drug used to treat tuberculosis for those with drug-resistant HIV/AIDS will be made available at a reduced cost and in more convenient regimens, saving as many as hundreds of thousands of lives in the developing world.
Three women who were diagnosed with HIV after getting “vampire facial” procedures at an unlicensed New...
The Biden administration is poised to make a landmark change to the federal government's position on...
Nearly half of all pregnancies worldwide are unplanned. And despite the many birth control options for...
